Related Experiment Videos
p53 gene mutations in asbestos associated cancers
1Institute of Occupational Medicine, Chinese Academy of Preventive Medicine, Beijing, China.
Biomedical and Environmental Sciences : BES
|December 23, 1998
Summary
Mutations in the p53 gene are common in asbestos-associated cancers. Analysis revealed specific mutation hotspots, suggesting a distinct mutational pattern compared to non-asbestos-related cancers.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The p53 tumor suppressor gene plays a critical role in preventing cancer.
- Mutations in p53 are frequently observed in various human cancers.
- Asbestos exposure is a known risk factor for several types of cancer.
Purpose of the Study:
- To investigate the frequency and spectrum of p53 gene mutations in asbestos-associated cancers.
- To identify potential mutation hotspots within the p53 gene in these cancer types.
Main Methods:
- Immunohistochemistry was used to detect mutant p53 protein accumulation.
- DNA was extracted from paraffin-embedded tumor tissues.
- Polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) and sequencing were employed to analyze p53 exons 5, 7, and 8.
Main Results:
- Mutant p53 protein was detected in 5 out of 10 asbestos-associated cancer cases.
- PCR-SSCP identified mutations in 7 cases, with a total of 8 mutations found.
- A high mutation frequency (80%) was observed in adenocarcinoma cases, with 50% of mutations located in exon 8.
- Sequencing revealed two hotspot mutations at codons 234 and 273.
Conclusions:
- The p53 gene frequently mutates in asbestos-associated cancers.
- The mutational spectrum of p53 in asbestos-associated cancers may differ from that in non-asbestos-associated cancers.
- Specific mutation hotspots were identified, warranting further investigation.